Metastatic Sarcomatoid Squamous Cell Carcinoma of the Cervix Presenting with Chest Mass

Abstract

Background Sarcomatoid squamous cell carcinoma is a rare and aggressive form of cervical cancer. We report a case of metastatic sarcomatoid squamous cell carcinoma (SSCC) of cervix that presented with an anterior chest wall mass. Case A 43-year-old Hispanic female presented with a two-month history of a central chest wall mass. The patient's only past medical history was SSCC of the cervix, stage IIB, diagnosed two years priorly. She underwent neoadjuvant chemoradiation therapy (CRT) with cisplatin followed by radical hysterectomy. Surgical margins were positive which led to adjuvant CRT with carboplatin and paclitaxel. PET scan 4 months after the postoperative treatment was negative for recurrence and metastatic disease. On current presentation, the CT chest revealed anterior mediastinal destructive soft tissue mass involving sternum, and the biopsy showed SSCC. The patient received palliative radiation therapy to her chest with improvement in pain and ability to swallow. After discussing the prognosis she refused further chemotherapy and decided on hospice care. Conclusion Despite good response to first-line therapy, SSCC tends to recur early and does not respond to second-line therapy. Radiation therapy seems to be the most effective modality for treatment, but randomized controlled trials of therapy are impractical.

Adamantinoma with a Prominent Spindle Cell Component Mimicking Intraosseous Synovial Sarcoma: Clinicopathological Features of Six Tumors

“…19, 20 A metastatic carcinoma would also be managed with adjuvant therapies and would be associated with a relatively poor prognosis. 25, 26…”

“…19,20 A metastatic carcinoma would also be managed with adjuvant therapies and would be associated with a relatively poor prognosis. 25,26 All six patients were treated with surgical resection in the present study. Given an initial diagnosis of metastatic carcinoma and Ewing sarcoma in the third case, the patient was offered three cycles of chemotherapy, elsewhere.…”